LISRAYA
NDC 87211-030, brepocitinib, tablet, film coated, from Priovant Therapeutics, Inc..
- Product NDC
- 87211-030
- Status
- Listed
- Labeler
- Priovant Therapeutics, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA220106
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/87211-030 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BREPOCITINIB TOSYLATE30 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 87211-030-30 | 87211003030 | 1 BOTTLE in 1 CARTON (87211-030-30) / 30 TABLET, FILM COATED in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/5023a17b-e96a-67d4-e063-6394a90a14a7
Use it
Look up 87211-030 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/87211-030 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 87211-030. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.